Press Releases
All Releases
 |
Spectrum Pharmaceuticals to Present at the 2010 Southern California Investor Conference
Aug 11, 2010
|
11.9 KB |
|
| |
IRVINE, Calif., Aug 11, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a biotechnology company
with fully integrated commercial and drug development operations with a
primary focus in oncology, today reported that an overview of the
Company's business strategy will be given at the 2010 Southern
...
|
|
Spectrum Pharmaceuticals Announces Second Quarter 2010 Corporate Update
Aug 9, 2010
|
24.5 KB |
|
| |
IRVINE, Calif., Aug 09, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a biotechnology company
with fully integrated commercial and drug development operations with a
primary focus in oncology, today reported financial results for the
three and six-months ended June 30, 2010.
"We are pleased with t...
|
|
Spectrum Pharmaceuticals Announces Date and Time of Second Quarter 2010 Corporate Update Conference Call
Aug 6, 2010
|
12.7 KB |
|
| |
IRVINE, Calif., Aug 06, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a biotechnology company
with fully integrated commercial and drug development operations with a
primary focus in hematology and oncology, today announced the date and
time for its second quarter 2010 corporate update and pipeline...
|
|
Spectrum Pharmaceuticals Appoints George Tidmarsh, M.D., Ph.D, as Senior Vice President, Chief Scientific Officer
Jul 19, 2010
|
22.8 KB |
|
| |
IRVINE, Calif., Jul 19, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a biotechnology company
with fully integrated commercial and drug development operations, with a
primary focus in hematology and oncology, today announced the
appointment of George Tidmarsh, M.D., Ph.D., to the position of Senior ...
|
|
Spectrum Pharmaceuticals Announces Results of Annual Meeting of Shareholders
Jul 1, 2010
|
20.7 KB |
|
| |
IRVINE, Calif., Jul 01, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage
biotechnology company with a focus in oncology and hematology, announced
the results of its annual meeting of shareholders, which was held today
at the Company's global corporate headquarters in Irvine, Califor...
|
|
Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer
Jun 23, 2010
|
22.1 KB |
|
| |
IRVINE, Calif., Jun 23, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage
biotechnology company with a focus in oncology and hematology, today
announced that it has appointed James E. Shields, a seasoned
pharmaceutical sales executive with a proven track record of
establishin...
|
|
Spectrum Pharmaceuticals Announces Adjournment of Annual Meeting of Shareholders until July 1, 2010
Jun 18, 2010
|
20.9 KB |
|
| |
IRVINE, Calif., Jun 18, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) today announced that it
has adjourned its Annual Meeting of Stockholders to 10:30a.m. Pacific
Time, Thursday, July 1, 2010, which will be held at the Company's
corporate office located at 157 Technology Drive, Irvine, California,
...
|
|
Spectrum Pharmaceuticals to Present at Two (2) Investor Conferences
Jun 7, 2010
|
21.2 KB |
|
| |
IRVINE, Calif., Jun 07, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (Nasdaq:SPPI), a commercial-stage
biotechnology company with a focus in oncology and hematology, announced
today that an overview of the Company's business strategy will be given
at two upcoming Investor Conferences.
...
|
|
Spectrum Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference on Wednesday, May 26
May 24, 2010
|
20.3 KB |
|
| |
IRVINE, Calif., May 24, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (Nasdaq:SPPI), a commercial-stage
biotechnology company with a focus in oncology and hematology, announced
today that an overview of the Company's business strategy will be given
at the 2010 Citi Investment Research Global Health Care Conference, ...
|
|
Spectrum Pharmaceuticals Announces Three Additional Belinostat Abstracts at the 2010 Annual Meeting of the American Society of Clinical Oncology
May 21, 2010
|
28.9 KB |
|
| |
IRVINE, Calif., May 21, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage
biotechnology company with a primary focus in hematology and oncology,
today announced that clinical data on belinostat will be presented at
the 2010 Annual Meeting of the American Society of Clinical Oncology ...
|
|
Spectrum Pharmaceuticals Announces Belinostat PTCL Abstract at the 2010 Annual Meeting of the American Society of Clinical Oncology
May 21, 2010
|
25.3 KB |
|
| |
IRVINE, Calif., May 21, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage
biotechnology company with a primary focus in hematology and oncology,
today announced that clinical data on belinostat will be presented at
the 2010 Annual Meeting of the American Society of Clinical Oncology ...
|
|
Spectrum Pharmaceuticals to Present at the 6th Annual Rodman & Renshaw Global Healthcare Conference on Tuesday, May 18th
May 14, 2010
|
20.3 KB |
|
| |
IRVINE, Calif., May 14, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage
biotechnology company with a focus in oncology and hematology, announced
today that an overview of the Company's business strategy will be given
at the 6th Annual Rodman & Renshaw Global Healthcare
Conf...
|
|
Spectrum Pharmaceuticals Announces First Quarter 2010 Corporate Update
May 10, 2010
|
33.1 KB |
|
| |
IRVINE, Calif., May 10, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage
biotechnology company with a primary focus in hematology and oncology,
today reported financial results for the first quarter ended March 31,
2010.
"With four anticancer drugs - two on the market and two in
...
|
|
Spectrum Pharmaceuticals Announces Date for First Quarter 2010 Corporate Update and Pipeline Review Conference Call
May 7, 2010
|
21.1 KB |
|
| |
IRVINE, Calif., May 07, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage
biotechnology company with a focus in oncology and hematology, today
announced the date and time for its first quarter 2010 corporate update
and pipeline review conference call.
Conference Call
...
|
|
Spectrum Pharmaceuticals to Present at the 2010 BIO International Convention Business Forum on Wednesday, May 5, 2010
May 3, 2010
|
19.7 KB |
|
| |
IRVINE, Calif., May 03, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage
biotechnology company with a focus in oncology, announced today that an
overview of the Company's business strategy will be given at the 2010
BIO International Convention Business Forum, taking place May 4-6, 20...
|
|
Spectrum Pharmaceuticals Announces Belinostat Data Presentation at 101st Annual Meeting of the American Association for Cancer Research
Apr 21, 2010
|
23.9 KB |
|
| |
IRVINE, Calif., Apr 21, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage
biotechnology company with a primary focus in oncology, today announced
results of a pre-clinical study conducted by the National Cancer
Institute of belinostat in the treatment of small-cell lung cancer that
...
|
|
Spectrum Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2009 Corporate Update
Apr 5, 2010
|
38.8 KB |
|
| |
IRVINE, Calif., Apr 05, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage
biotechnology company with a primary focus in oncology, today reported
financial results for the fourth quarter and fiscal year ended December
31, 2009.
Company Operations and Performance
"The year 2009 was f...
|
|
Spectrum Pharmaceuticals Announces Delay in Filing 2009 Annual Report on Form 10-K
Apr 1, 2010
|
19.8 KB |
|
| |
IRVINE, Calif., Apr 01, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage
biotechnology company with a primary focus in oncology, today announced
that it missed the deadline of March 31, 2010, for the filing of its
2009 Annual Report on Form 10-K with the U.S. Securities & Exchange
...
|
|
Spectrum Pharmaceuticals Announces a National Cancer Institute-Sponsored Phase 1/2 Study of Belinostat in Thymic Malignancies
Mar 22, 2010
|
24.8 KB |
|
| |
IRVINE, Calif., Mar 22, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage
biotechnology company with a primary focus in oncology and hematology,
and TopoTarget A/S, today announced that the first patient has been
dosed in a National Cancer Institute (NCI)-sponsored Phase 1/2 trial of ...
|
|
Spectrum Pharmaceuticals to Present at the 22nd Annual Roth Capital Markets Growth Conference on Monday, March 15
Mar 11, 2010
|
20.2 KB |
|
| |
IRVINE, Calif., Mar 11, 2010 (BUSINESS WIRE) -- Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage
biotechnology company with a focus in oncology, announced today that an
overview of the Company's business strategy will be given at the 22nd
Annual ROTH Capital Markets Conference on Monday, March 15, 2010, at ...
|
|
|
=add release to Briefcase |
| Stock Information |
NASDAQ:SPPI
$3.86
+ 0.08
|
Sep 2, 2010
4:00 PM ET |
Quotes delayed at least 20 minutes.
Information provided by eSignal.
| Search Investor Relations |
|
|
